These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Flow cytometric characterization of cell populations in bronchoalveolar lavage and bronchial brushings from patients with chronic obstructive pulmonary disease. Hodge SJ; Hodge GL; Holmes M; Reynolds PN Cytometry B Clin Cytom; 2004 Sep; 61(1):27-34. PubMed ID: 15351979 [TBL] [Abstract][Full Text] [Related]
10. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Ferhani N; Letuve S; Kozhich A; Thibaudeau O; Grandsaigne M; Maret M; Dombret MC; Sims GP; Kolbeck R; Coyle AJ; Aubier M; Pretolani M Am J Respir Crit Care Med; 2010 May; 181(9):917-27. PubMed ID: 20133931 [TBL] [Abstract][Full Text] [Related]
12. Long-term smoking alters abundance of over half of the proteome in bronchoalveolar lavage cell in smokers with normal spirometry, with effects on molecular pathways associated with COPD. Yang M; Kohler M; Heyder T; Forsslund H; Garberg HK; Karimi R; Grunewald J; Berven FS; Magnus Sköld C; Wheelock ÅM Respir Res; 2018 Mar; 19(1):40. PubMed ID: 29514648 [TBL] [Abstract][Full Text] [Related]
13. Distribution of T-cell subsets in BAL fluid of patients with mild to moderate COPD depends on current smoking status and not airway obstruction. Forsslund H; Mikko M; Karimi R; Grunewald J; Wheelock ÅM; Wahlström J; Sköld CM Chest; 2014 Apr; 145(4):711-722. PubMed ID: 24264182 [TBL] [Abstract][Full Text] [Related]
14. YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. Létuvé S; Kozhich A; Arouche N; Grandsaigne M; Reed J; Dombret MC; Kiener PA; Aubier M; Coyle AJ; Pretolani M J Immunol; 2008 Oct; 181(7):5167-73. PubMed ID: 18802121 [TBL] [Abstract][Full Text] [Related]
15. Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers. Löfdahl JM; Wahlström J; Sköld CM Clin Exp Immunol; 2006 Sep; 145(3):428-37. PubMed ID: 16907910 [TBL] [Abstract][Full Text] [Related]
16. Gender differences in the T-cell profiles of the airways in COPD patients associated with clinical phenotypes. Forsslund H; Yang M; Mikko M; Karimi R; Nyrén S; Engvall B; Grunewald J; Merikallio H; Kaarteenaho R; Wahlström J; Wheelock ÅM; Sköld CM Int J Chron Obstruct Pulmon Dis; 2017; 12():35-48. PubMed ID: 28053515 [TBL] [Abstract][Full Text] [Related]
17. Abnormal M1/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD). Eapen MS; Hansbro PM; McAlinden K; Kim RY; Ward C; Hackett TL; Walters EH; Sohal SS Sci Rep; 2017 Oct; 7(1):13392. PubMed ID: 29042607 [TBL] [Abstract][Full Text] [Related]
18. Lung chitinolytic activity and chitotriosidase are elevated in chronic obstructive pulmonary disease and contribute to lung inflammation. Létuvé S; Kozhich A; Humbles A; Brewah Y; Dombret MC; Grandsaigne M; Adle H; Kolbeck R; Aubier M; Coyle AJ; Pretolani M Am J Pathol; 2010 Feb; 176(2):638-49. PubMed ID: 20042671 [TBL] [Abstract][Full Text] [Related]
19. The MIF Antagonist ISO-1 Attenuates Corticosteroid-Insensitive Inflammation and Airways Hyperresponsiveness in an Ozone-Induced Model of COPD. Russell KE; Chung KF; Clarke CJ; Durham AL; Mallia P; Footitt J; Johnston SL; Barnes PJ; Hall SR; Simpson KD; Starkey MR; Hansbro PM; Adcock IM; Wiegman CH PLoS One; 2016; 11(1):e0146102. PubMed ID: 26752192 [TBL] [Abstract][Full Text] [Related]
20. Imbalance between subpopulations of regulatory T cells in COPD. Hou J; Sun Y; Hao Y; Zhuo J; Liu X; Bai P; Han J; Zheng X; Zeng H Thorax; 2013 Dec; 68(12):1131-9. PubMed ID: 23749814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]